Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Samuel Lesourd"'
Autor:
Clélia Coutzac, Frederic Bibeau, Meher Ben Abdelghani, Thomas Aparicio, Romain Cohen, Elodie Coquan, Olivier Dubreuil, Ludovic Evesque, François Ghiringhelli, Stefano Kim, Samuel Lesourd, Cindy Neuzillet, Jean-Marc Phelip, Guillaume Piessen, Philippe Rochigneux, Emmanuelle Samalin, Emilie Soularue, Yann Touchefeu, David Tougeron, Aziz Zaanan, Christelle de la Fouchardière
Publikováno v:
Digestive and Liver Disease
Digestive and Liver Disease, 2022, 54 (10), pp.1335-1341. ⟨10.1016/j.dld.2022.07.008⟩
Digestive and Liver Disease, 2022, 54 (10), pp.1335-1341. ⟨10.1016/j.dld.2022.07.008⟩
International audience; Background: Immune checkpoint inhibitors (ICI) targeting Programmed death-1 (PD-1) have shown their efficacy in advanced MSI/dMMR (microsatellite instability/deficient mismatch repair) tumors. The MSI/dMMR status predicts clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f54d5c46065bce3549e79b161db7c16c
https://hal.science/hal-03837196/file/PIIS1590865822005916.pdf
https://hal.science/hal-03837196/file/PIIS1590865822005916.pdf
Autor:
Abrigeon, Constance D., Mairéad Mcnamara, Samuel LeSourd, Angela Lamarca, Astrid Lievre, Richard Hubner, Juan Valle, Julien Edeline
Publikováno v:
University of Manchester-PURE
Journal of Clinical Oncology
Journal of Clinical Oncology, 2022, 40 (4), pp.475-475. ⟨10.1200/JCO.2022.40.4_suppl.475⟩
Journal of Clinical Oncology
Journal of Clinical Oncology, 2022, 40 (4), pp.475-475. ⟨10.1200/JCO.2022.40.4_suppl.475⟩
475 Background: Cirrhosis is a risk factor for intrahepatic cholangiocarcinoma (iCC). However, its impact on the management of advanced disease is not established. Methods: Retrospective analysis of patients (pts) treated with systemic chemotherapy f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40da94ce2460a995464ca017b48534d4
https://www.research.manchester.ac.uk/portal/en/publications/influence-of-cirrhosis-on-outcomes-of-patients-with-advanced-intrahepatic-cholangiocarcinoma-receiving-chemotherapy(1144e1bf-5522-4e8d-a400-bfc74598d607).html
https://www.research.manchester.ac.uk/portal/en/publications/influence-of-cirrhosis-on-outcomes-of-patients-with-advanced-intrahepatic-cholangiocarcinoma-receiving-chemotherapy(1144e1bf-5522-4e8d-a400-bfc74598d607).html